MedTrace Logo

Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic

NCT07317687 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-01-20

No results posted yet for this study

Summary

West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.

Conditions

  • HIV Testing
  • HEPATITIS C (HCV)
  • Syphilis
  • Hepatitis B Virus (HBV)

Interventions

DIAGNOSTIC_TEST

Blood Draw for lab test

Blood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results

DIAGNOSTIC_TEST

Rapid Fingerstick Test

Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes

Sponsors & Collaborators

  • West Virginia University

    lead OTHER

Principal Investigators

  • Madison Humerick, MD · West Virginia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07317687 on ClinicalTrials.gov